CAS 2313526-86-0
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 produits concernés.
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS :Formule :C21H19F3N4O4Degré de pureté :99.92%Masse moléculaire :448.3952N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-Methoxybenzamide
CAS :N-(2-(1H-1,2,4-Triazol-1-Yl)-5-(Trifluoromethoxy)Phenyl)-4-(Cyclopropylmethoxy)-3-MethoxybenzamideDegré de pureté :98%Masse moléculaire :448.4g/molN-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS :<p>N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally bioavailable and to have an effect on the spinal cord. This drug is effective in doses ranging from 1 mg/kg to 10 mg/kg. N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is still in preclinical stages and has not been tested on humans yet.</p>Formule :C21H19F3N4O4Degré de pureté :Min. 95%Masse moléculaire :448.4 g/molVU6012962
CAS :VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: 347 nM).Formule :C21H19F3N4O4Degré de pureté :99.61% - 99.74%Couleur et forme :SolidMasse moléculaire :448.4
